Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

This study has been completed.
Lymphoma Study Association
Information provided by (Responsible Party):
French Innovative Leukemia Organisation Identifier:
First received: May 27, 2009
Last updated: March 15, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)